Farah Champsi, 10% Owner at Esperion Therapeutics, Inc. (ESPR), bought 2,052,189 shares at $14.00 ($3.3M) on 2013-07-01, disclosed to the SEC on 2013-07-01.
Open-market purchase of $3.3M ESPR by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,816,475 | $0 | 0.0% |
| 2 | $14.00 | 235,714 | $3.3M | 100.0% |
| Total | $1.61 avg | 2,052,189 | $3.3M | 100% |
| Filing → |
| KITE | SELL | 2017-04-26 | $20.5M | — | Filing → |
| KITE | SELL | 2017-04-17 | $19.0M | — | Filing → |
| KITE | SELL | 2015-07-02 | $41.4M | — | Filing → |